
|Videos|July 22, 2021
Vyluma pipeline focuses on refractive error
Advertisement
Vyluma, which recently spun off from Nevakar, has a robust pipeline for potential therapies addressing refractive error. Navneet Puri, PhD, the company’s founder, chairman, and CEO, offers additional insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Georgia university receives state funding for state's first college of optometry
2
Practical tips and tricks: Drs Jeffrey J. Walline, Erin Tomiyama weigh in on myopia management
3
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
4
Recent study findings may prove previous estimations of retinal cell communication, low-light vision
5





















